Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allergan Inc (AGN) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Allergan Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 850693.
Total stock buying since 2015: $0.
Total stock sales since 2015: $0.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2015 | 0 | $0 | 0 | $0 | 19,957 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2015-03 | 0 | $0 | 0 | $0 | 17,575 | $0 |
| 2015-02 | 0 | $0 | 0 | $0 | 2,382 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-17 | Proctor Timothy D (Director) | Option Ex | 1,189 | .00 | 0 |
| 2015-03-17 | Dunsire Deborah (Director) | Option Ex | 8,859 | .00 | 0 |
| 2015-03-17 | Jones Trevor M (Director) | Option Ex | 7,527 | .00 | 0 |
| 2015-02-20 | Gangolli Julian S (CVP & Pres, North America) | Option Ex | 514 | .00 | 0 |
| 2015-02-20 | Diradoorian Raymond H (EVPGlobal Technical Operations) | Option Ex | 277 | .00 | 0 |
| 2015-02-20 | Whitcup Scott M (Executive VP, R&D, CSO) | Option Ex | 212 | .00 | 0 |
| 2015-02-20 | Pyott David E I (Chairman of the Board and CEO) | Option Ex | 1,379 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of AGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Allergan Inc (symbol AGN, CIK number 850693) see the Securities and Exchange Commission (SEC) website.